Media center

Haz click aquí para leer este posicionamiento en español. WASHINGTON D.C., United States, 3 February 2025 – The Trump administration is using foreign aid as a deadly political weapon, ILGA World and International Planned Parenthood Federation (IPPF) said today, and millions of people are already in dire straits because of its policies. The executive order implementing a 90-day pause in US foreign development aid is wreaking havoc on the lifesaving work of human rights, civil society, and grassroots organisations —according to ILGA World and IPPF. Sexual and reproductive health services suddenly were forced to suddenly stop or drastically cut operations, including those further impacted by the reinstatement of the Global Gag Rule, leaving millions of people without access to lifesaving care. The funding suspension initially impacted also the over 20 million people living with HIV directly supported through the United States President's Emergency Plan for AIDS Relief (PEPFAR). Later, however, a life-saving humanitarian assistance waiver” walked back the decision, yet excludes activities related to abortion or family planning, gender or DEI programs, gender-affirming  surgeries, and other activities deemed to be “non-life saving assistance.” IPPF anticipates it will lose US$61 million from cuts due to refusing to sign the Global Gag Rule. Programs affected - mainly in Africa - provide sexual and reproductive health services for millions of women and youth, many of whom will be forced to continue with a pregnancy they did not want or have an unsafe abortion they may not survive. United Nations agencies have begun cutting back their global aid operations as a direct consequence of the 90-day foreign aid suspension. Without guaranteed funding, implementing organisations will have no choice but to lay off thousands of health workers and programme staff. Even if funds are reinstated after the “assessment of consistency with US foreign policy”, the bottoming out of the health sector means there are no guarantees that  organisations will be able to continue serving our communities. “The US, currently the largest provider of Official Development Assistance (ODA), is choosing to leave behind the already most marginalised people across the world, in the name of far-right regressive policies,” said ILGA World and IPPF.  “This is a war on development. People will die because the Trump administration is using life-saving funding as a leverage to advance a hateful  dystopia.  American aid with further conditionality will be unable to reach the most vulnerable populations, undoing decades of progress on health, security and human rights.” “This devastating blow to foreign aid risks worsening humanitarian crises, violence, conflict, and political instability,” ILGA World and IPPF conclude. “This is the opposite of building ‘harmonious and stable relations internal to and among countries’ that the Trump administration claims to seek.” “Now more than ever, we are in solidarity with our global movements. We will continue to fight alongside them. We will not be fearful or silenced; but instead use this moment to galvanise our communities. But we need to be prepared: vital resources and life-saving programmes may not come back — at least not without severe limitations and exclusionary conditions.”  “We call on more States to step in with development aid, listen to the needs and priorities of grassroots communities, and provide them with a lifeline.” Note to editors ILGA World is a worldwide federation of more than 2,000 organisations from over 170 countries and territories campaigning for the human rights of people with diverse sexual orientations, gender identities and expressions, and sex characteristics. The International Planned Parenthood Federation (IPPF) is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Founded in 1952, it is now a movement of 150 member associations and collaborative partners with a presence in over 146 countries.  For ILGA World: Daniele Paletta (communications manager); [email protected]; time zone: UTC+1 For IPPF: Nerida Williams (senior media advisor); [email protected]; time zone: UTC+7 Alice Ackermann (communications advisor); [email protected]; time zone: UTC+1

January 21, 2025—The International Planned Parenthood Federation (IPPF) strongly condemns the Trump administration’s decision to withdraw financial support from the World Health Organization (WHO). This executive order will have devastating consequences for Americans, global health and the communities we serve. This decision, which gives a one-year notice before taking effect, will severely undermine the WHO’s capacity to carry out its critical mission and will cost lives.  As the largest single contributor to the WHO, the United States provides approximately 18% of the organization’s funding, with the current two-year budget for 2024-2025 set at $6.8 billion. The withdrawal of U.S. funding will create an unprecedented financial shortfall, threatening essential health programs, partnerships and global public health.  Since its establishment in 1948 as part of the United Nations, the WHO has been at the forefront of global health initiatives. From combatting malaria and tuberculosis to improving women’s and children’s health, nutrition, and sanitation, the WHO’s role in coordinating international health policy, prevention and disease eradication is indispensable. Today, it serves as a vital hub for research, technical support, and health trend monitoring, addressing some of the world’s most pressing health challenges, including sexual and reproductive health and rights.  The global maternal mortality ratio has stagnated since 2016 at around 223 maternal deaths per 100 000 live births. Only one WHO region (the South-East Asia Region) has recorded a significant decline in maternal mortality, while all other regions have recorded either a stagnation or an increase. "Defunding the WHO is a direct attack on the health and well-being of millions, especially the most vulnerable,” said Dr Alvaro Bermejo, IPPF’s Director-General. “Donald Trump’s decision to strip the WHO of its funding, before the expansion of the Global Gag Rule, adds further insult to injury. The health community has collectively endured unprecedented attacks against health care workers, patients and clinics, made possible with the previous US administration. Peace is the best medicine; we urge the Trump Administration to reconsider its position. The world needs a thriving WHO. Women, girls and LGBTQ+ people all over the world need a thriving IPPF. IPPF stands in solidarity with Dr Tedros Adhanom Ghebreyesus and with the WHO. We will continue to resist, and we will continue to fight for peace, and for sexual and reproductive health, rights and justice for ALL.”  IPPF calls on the international community to stand in solidarity with the WHO and to work together to mitigate the catastrophic impact of this funding withdrawal. The lives and health of countless individuals are at stake, and we must act urgently to ensure that global health systems remain strong and resilient.  For more information please contact [email protected] - +44 7918 845944 About the International Planned Parenthood Federation  IPPF is a global healthcare provider and a leading advocate of sexual and reproductive health and rights (SRHR) for all. Led by a courageous and determined group of women, IPPF was founded in 1952 at the Third International Planned Parenthood Conference. Today, we are a movement of 158 Member Associations and Collaborative Partners with a presence in over 153 countries.  Our work is wide-ranging, including comprehensive sex education, provision of contraceptive, safe abortion, and maternal care and responding to humanitarian crises. We pride ourselves on being local through our members and global through our network. At the heart of our mission is the provision of – and advocacy in support of – integrated healthcare to anyone who needs it regardless of race, gender, sex, income, and crucially no matter how remote. 

Texas judge, Matthew Kacsmaryk, has suspended the U.S. Food and Drug Administration's (FDA) approval of the abortion pill Mifepristone in a horror move for abortion access across the United States. The decision will result in a nationwide ban on Mifepristone in seven days, with the FDA given one week to appeal the ruling. While the ban also affected access in states that have secured abortion post-Roe v Wade, a conflicting ruling from Judge Thomas O. Rice from a federal court in Washington state ordered the FDA to maintain access to Mifepristone in 17 democratic states and Colombia District – effectively putting access to the pill into limbo. Mifepristone, which has been FDA-approved for more than 22 years and has a safety record of over 99%[i], is taken alongside the drug Misoprostol during medical abortion procedures. Since then, it has been used by over 5 million[ii] Americans and was used in more than half of abortions nationwide last year. While Misoprostol can be used alone in medical abortion, people should have access to the full spectrum of abortion care options. Mifepristone is also used in the medical management of miscarriage and second and third-trimester pregnancies when the fetus has died before birth. While the ruling does not prohibit the FDA from making a new authorization for Mifepristone, this will likely take many months. Severe disruption to abortion care services, healthcare services and supply chain issues are expected as healthcare providers and pharmacies grapple with legality, stock, retraining and reeducation. Beth Schlachter, Director of Global Advocacy for the International Planned Parenthood Federation, said: "For 22 years, Mifepristone has been safely used in medical abortion care across the U.S., allowing healthcare providers to deliver safe, practical and discreet care to people who have chosen to end their pregnancies, regardless of their economic status or ability to travel. "In one fell swoop, anti-abortion extremists have once again stripped people of their rights in another blow to liberty. This horror ruling based on junk science, wilful distortion of fact and extreme political agendas will profoundly affect the lives of millions of people already struggling to access the care they need, especially in states where abortion is already banned." Anti-abortion extremists deliberately filed the case against the approval of Mifepristone in the Amarillo division of the Northern District of Texas — a single-judge division where cases are automatically assigned to Judge Matthew Kacsmaryk, a conservative judge appointed by former President Trump. The group claim that: "the statutory basis on which the FDA's approval of Mifepristone was issued 22 years ago is invalid" - an assertion both the Government Accountability Office and FDA have previously investigated and put to rest "an 1873 vice law that made it illegal to send "obscene, lewd or lascivious" material through the mail applies to abortion pills" - federal courts have consistently ruled it doesn't apply to lawful abortions "the drug's original approval wasn't supported by evidence of safety and efficacy" — a claim that medical and policy experts have continuously discredited Beth Schlachter, added: "The implementation of a national ban on Mifepristone via a state court debunks one of the principal anti-abortion arguments in the Roe v Wade case  - that the ruling curtailed state freedom and that abortion rights should be defined on a state-by-state basis. "This weaponization of federal courts by anti-abortion extremists proves just how dangerous the overturning of Roe v Wade is for everyday Americans, whose access to healthcare now lies in the hands of fanatical religious extremists determined to disrupt, harass and deceive until they end access to abortion care and long-held sexual and reproductive rights for good." The International Planned Parenthood Federation's local partner, the Planned Parenthood Federation of America, will continue to provide abortion care where safe and legal to do so. Those seeking medical abortion can also access care via AidAccess and WomenonWeb. At least two abortion networks, Trust Women and Whole Womans Health, have also announced that they will not immediately stop prescribing Mifepristone and will await a directive from the FDA – a move known as a conscientious provision which refers to providers who continue to provide care despite the legal parameters.   Alongside its partner and other reproductive health organizations, IPPF will keep fighting for access to abortion care, freedom from stigma and freedom from criminalization until everyone, everywhere, is free to make choices about their sexuality and well-being. [i] https://www.plannedparenthood.org/uploads/filer_public/42/8a/428ab2ad-3798-4e3d-8a9f-213203f0af65/191011-the-facts-on-mifepristone-d01.pdf [ii] Ibid For media enquiries, please contact Karmen Ivey at [email protected] or [email protected]   About the International Planned Parenthood Federation The International Planned Parenthood Federation (IPPF) is a global service provider and advocate of sexual and reproductive health and rights for all.  For 70 years, IPPF, through its 118 Member Associations and seven partners, has delivered high-quality sexual and reproductive healthcare and helped advance sexual rights, especially for people with intersectional and diverse needs that are currently unmet. Our Member Associations and partners are independent organizations that are locally owned, which means the support and care they provide is informed by local expertise and context. We advocate for a world where people have the information they need to make informed decisions about their sexual health and bodies. We stand up and fight for sexual and reproductive rights and against those who seek to deny people their human right to bodily autonomy and freedom. We deliver care that is rooted in rights, respect, and dignity - no matter what.  

Profamilia – an IPPF Member Association and the leading sexual and reproductive rights organization in Colombia – is celebrating the first anniversary of the decriminalization of abortion across the country. The move - Ruling C-055 - which allows abortion up to 24 weeks of gestation under any circumstance is saving lives across Colombia, and means those who have an abortion no longer face prosecution or criminalization. A historic step for the rights of women and pregnant people both in the country and across Latin America. Over the last year, Profamilia via its nationwide network of more than 50 clinics has helped guarantee sexual and reproductive health and rights, focusing on providing safe abortion care services in person as well as the provision of telemedicine for rural women.   For a country which sees 132,000 cases annually of complications from unsafe abortions and 70 women lose their lives each year – the shift in focus to abortion as a public health issue means healthcare providers can now focus on providing life-saving care and ending unsafe abortion. Alongside the ruling, the Ministry of Health, has also regulated abortion services throughout Colombia via Resolution 051, reiterating that abortion is an essential and urgent health service, which women, including migrant women, and pregnant people (transgender men, trans masculinities, non-binary people, among others) must be able to access without restriction and for free. Further rulings also embeds the provision of sexual and reproductive health information into Colombian health services. Marta Royo, the Executive Director of ProFamilia, said: "Profamilia's commitment will always be to provide comprehensive, humanized and safe services that allow free and informed decision making, and we reiterate this today” "After one year it is possible to see the progress the country has made in terms of reproductive autonomy and rights for women and pregnant people. However, we must move from text to action, and ensure that decriminalization means healthcare. Profamilia's commitment will always be to provide comprehensive, humanized and safe services that allow free and informed decision making." Eugenia López Uribe, Regional Director of IPPF for the Americas and The Caribbean.